Clinical Trial Update: Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

This Phase 2 trial assessed rituximab in combination with chemotherapy for patients with previously untreated mantle cell lymphoma. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: University of Miami | Conditions: Mantle-Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2025-07-23